Analgesics in Azerbaijan

  • ID: 1830047
  • Report
  • Region: Azerbaijan
  • 19 pages
  • Euromonitor International
1 of 4
While volume sales of analgesics declined significantly in 2017, value sales fell by a slower rate due to inflated prices because of the weakened local currency. Since analgesics are represented by international players, the significantly depreciated manat resulted in imports that are more expensive against a backdrop of reduced consumer income. Sales were also affected by consumers trading down from mass products to analgesics with economy claims.

The Analgesics in Azerbaijan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 4
ANALGESICS IN AZERBAIJAN

List of Contents and Tables
  • Headlines
  • Prospects
  • Macroeconomic Situation and State Regulation Determine Analgesics Sales Dynamics
  • Topical Analgesics/anaesthetic Gain Value Share Due To Softer Price Controls and Active Consumer Lifestyles
  • Drugstores/parapharmacies Remains the Key Distribution Channel
  • Competitive Landscape
  • International Players Lead Analgesics
  • Actavis Group Retains Leading Position in 2017
  • Reduced Consumer Purchasing Power Drives Sales of Generics
  • Category Data
  • Table 1 Sales of Analgesics by Category: Value 2012-2017
  • Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
  • Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  • Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
  • Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
  • Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
  • Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
  • Executive Summary
  • Inflation and State Regulation of Pharmaceutical Prices Drive Consumer Health Value Growth in 2017
  • Consumers More Price-conscious Due To Economic Turmoil With Consequent Revaluated Pricing and Business Strategies by Manufacturers
  • Consumer Health Is Led by International Players
  • Parapharmacies Grow, Striving To Provide More Convenient Shopping for Customers
  • Consumer Health Is Expected To Post Steady Value Growth Over the Forecast Period
  • Market Indicators
  • Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  • Table 9 Life Expectancy at Birth 2012-2017
  • Market Data
  • Table 10 Sales of Consumer Health by Category: Value 2012-2017
  • Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
  • Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
  • Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
  • Table 14 Distribution of Consumer Health by Format: % Value 2012-2017
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2017
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2017-2022
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
  • Appendix
  • OTC Registration and Classification
  • Vitamins and Dietary Supplements Registration and Classification
  • Self-medication/self-care and Preventive Medicine
  • Switches
  • Sources
  • Summary 1 Research Sources
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll